Open AccessFostering Production of Pharmaceutical Products in Developing Countries
Author(s) -
William W. Fisher,
Ruth Okediji,
Padmashree Gehl Sampath
Publication year - 2022
Publication title -
michigan journal of international law
Language(s) - English
Resource type - Journals
eISSN - 2688-5522
pISSN - 1052-2867
DOI - 10.36642/mjil.43.1.fostering
Subject(s) - developing country , malaria , tuberculosis , medicine , developed country , environmental health , business , economic growth , development economics , economics , population , pathology , immunology
The residents of developing countries need pharmaceutical products at least as much as the residents of developed countries. Noncommunicable diseases (such as cancers, cardiovascular disease, and mental-health disorders), which typically are most effectively treated with drugs, are now nearly as common in developing countries as in developed countries. And communicable diseases (such as tuberculosis, HIV, and malaria), the prevention or treatment of which also typically require drugs, continue to be substantially more common in the developing world.